Mark Warner Discusses Proposed Changes to Drug Price Regulation in Canada and Implications for U.S. – Canada Trade Relations

Mark Warner was interviewed on the Canada Talks SiriusXM 167 Arlene Bynun Show about the Canadian Government’s proposals to delete Switzerland and the United States from index of countries used to set drug prices in Canada. (August 12, 2019) These proposals have implications for President Trump’s proposals to facilitate the import of certain drugs from Canada, and are similar to proposals under discussion between President Trump and Congress and may factor in the ongoing efforts to pass the United States Mexico Canada Agreement (USMCA) / (NAFTA 2.0). Mr. Warner was Legal Director of the Ontario Ministry of Economic Development & Trade and advised Ontario in the negotiation of the Canada – EU Trade Agreement (CETA) including on drug pricing and patent appeals and on other trade and investment negotiation and dispute settlement matters including NAFTA . Mr. Warner, a Canadian and U.S. lawyer, has advised pharmaceutical companies on pricing, distribution and other competition and trade matters. Mr. Warner has also governments on trade policy and trade negotiations and previously worked on trade and competition issues as counsel in the OECD Trade Directorate.